AmbetterExchange · Coverage · Coding · KY · PathologyHigh impact
Update for CPT Codes 80320-80377: Effective 10/1/2026
Effective date
Oct 1, 2026
Identified
Oct 15, 2026
Summary
Effective October 1, 2026, CPT codes 80320-80377 (Definitive Drug Testing Procedures) will no longer be reimbursable. Providers must transition to billing appropriate G-series bundled laboratory codes instead. This is a historical discovery of a policy that became effective on the analysis date.
Get alerts when payers change rules like this one
We check Ambetter and other payers every day and email you when a change matches your specialty and state.
01As of October 1, 2026, CPT codes 80320-80377 are no longer reimbursable and this change is now effective.
02Verify whether the practice has already implemented the transition to G-series bundled laboratory codes in the billing system and confirm current claim submission procedures.
03Billing team should audit recent claims (on or after 10/1/2026) submitted under these codes and contact Provider Relations Representative at Ambetter Health to clarify coverage status, identify appropriate G-series replacement codes, and address any claims that may require correction or resubmission.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.